Key facts
- It has raised $1.5M; the latest was Later Stage VC in Jun 2025.
- Notable investors include Taiyou Fund, Beijing Shangshi Investment Management, Leton Capital, Qingdao Institute of Bioenergy and Bioprocess Technology.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Smart Cyano
- ·The full record, as it builds
Funding rounds
No funding rounds for Smart Cyano are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Smart Cyano
Developer of active ingredients designed for the biological field. The company's main product is glycerol glucoside, is synthesised in natural algae cells and has the characteristics of pure naturalness, high purity, and high physiological activity, providing customers with high-quality products.
- Sector
- Materials and Resources
- HQ
- Qingdao, China
- Founded
- 2018
- Employees
- 5
- Website
- zklzbiotech.com/
- Ownership
- Privately Held (backing)
Smart Cyano doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Smart Cyano shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Smart Cyano in its N-PORT filings yet. We sweep new filings monthly.